Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (221-230 of 471) with videos related to

Pageof 48
Sort By:
The American Journal of Cardiology|January 21, 2014
Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials)Philippe Généreux, Mahesh V Madhavan, Gary S Mintz, et al.
Journal of Interventional Cardiology|June 9, 2023
Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center StudyClaudia See, Yanting Wang, Haocheng Huang, et al.
The American Journal of Cardiology|July 31, 2003
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit, Roxana Mehran, Gary S Mintz, et al.
European Heart Journal|June 9, 2007
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The American Journal of Cardiology|October 13, 2004
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas, Eve D Aymong, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2018
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All ComersAndreas Baumbach, Alexandra J Lansky, Yoshinobu Onuma, et al.
The American Journal of Cardiology|January 11, 2003
Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary interventionMagdi M El-Omar, George Dangas, Roxana Mehran, et al.
The American Journal of Cardiology|November 29, 2011
Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy)So-Yeon Choi, Akiko Maehara, Ecaterina Cristea, et al.
American Heart Journal|June 20, 2006
Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trialBruce R Brodie, Gregg W Stone, David A Cox, et al.
Journal of the American Heart Association|May 15, 2025
Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device-Supported High-Risk Percutaneous Coronary Intervention: The PROTECT III StudyGuillaume Bonnet, Karl-Philipp Rommel, Batla Falah, et al.
Pageof 48

Showing results (221-230 of 471) with videos related to

Sort By:
Pageof 48
The American Journal of Cardiology|January 21, 2014
Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials)Philippe Généreux, Mahesh V Madhavan, Gary S Mintz, et al.
Journal of Interventional Cardiology|June 9, 2023
Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center StudyClaudia See, Yanting Wang, Haocheng Huang, et al.
The American Journal of Cardiology|July 31, 2003
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)Thosaphol Limpijankit, Roxana Mehran, Gary S Mintz, et al.
European Heart Journal|June 9, 2007
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The American Journal of Cardiology|October 13, 2004
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas, Eve D Aymong, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2018
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All ComersAndreas Baumbach, Alexandra J Lansky, Yoshinobu Onuma, et al.
The American Journal of Cardiology|January 11, 2003
Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary interventionMagdi M El-Omar, George Dangas, Roxana Mehran, et al.
The American Journal of Cardiology|November 29, 2011
Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy)So-Yeon Choi, Akiko Maehara, Ecaterina Cristea, et al.
American Heart Journal|June 20, 2006
Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trialBruce R Brodie, Gregg W Stone, David A Cox, et al.
Journal of the American Heart Association|May 15, 2025
Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device-Supported High-Risk Percutaneous Coronary Intervention: The PROTECT III StudyGuillaume Bonnet, Karl-Philipp Rommel, Batla Falah, et al.
Pageof 48